Marie Duranteau
InvestorAnalyst at Sofinnova Partners
Paris, France
Writes $100K – $5M checks · typically $1.5M
About
Marie Duranteau is a biotech strategy consultant with training in science and over eight years of experience at Sofinnova Partners evaluating oncology programs across Europe. She has led end-to-end preclinical program management across multiple modalities including cell therapy, ADCs, and bispecific antibodies, and has supported the development of portfolio companies including Signadori Bio and Inizio Due. Duranteau has experience coordinating cross-functional teams and securing non-dilutive funding for early-stage biotech initiatives.
Experience
- FreelanceIndependent Consultant, Biotech Strategycurrent2026 — presentParis, Île-de-France, France
- Sofinnova PartnersAssociate & Program Manager, BioVelocita Strategy2023 — 2025Paris, Île-de-France, France
- Sofinnova PartnersSenior Analyst, Capital Strategy2022 — 2024Paris, Île-de-France, France
- Sofinnova PartnersAnalyst, Capital Strategy2020 — 2022Paris, Île-de-France, France
- Sofinnova PartnersJunior Analyst, Capital Strategy2018 — 2020Paris, Île-de-France, France
- Sofinnova PartnersIntern, Capital Strategy2017 — 2018Paris, Île-de-France, France
- Institut Jacques MonodPost-doctoral Researcher Cell Biology - Labex "Who Am I ?"2015 — 2016Karess' Lab - Région de Paris, France
- Institut Jacques MonodPhD Cell Biology Université Paris Cité2012 — 2015Karess' Lab - Région de Paris, France
Skills & more
Drug DevelopmentCRO ManagementCross-functional CoordinationProgram ManagementPre-clinical StudiesCompetitive AnalysisDeal FlowOncologyScientific CommunicationsExperimental DesignPeople ManagementScientific Due Diligence
+4 more
Translational research analysisTranslational Literature ReviewScientific ScoutingScientific Data AnalysisLanguages Anglais · Français
- CBA Certificate in Business Administration for PhDs — Université Sorbonne Paris Cité
From Marie's professional profile.
Colleagues at Sofinnova Partners
Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners
Network3
Anne Osdoit
Partner, MD Start Strategy at Sofinnova Partners
Anta Gkelou
Partner, Capital Strategy at Sofinnova Partners
Gonzague Issenmann
Investor at Sofinnova Partners
Investors connected to Marie in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Marie Duranteau?
- Marie Duranteau is a biotech strategy consultant with training in science and over eight years of experience at Sofinnova Partners evaluating oncology programs across Europe. She has led end-to-end preclinical program management across multiple modalities including cell therapy, ADCs, and bispecific antibodies, and has supported the development of portfolio companies including Signadori Bio and Inizio Due. Duranteau has experience coordinating cross-functional teams and securing non-dilutive funding for early-stage biotech initiatives.
- Where does Marie Duranteau work?
- Marie Duranteau is Analyst at Sofinnova Partners.
- What check size does Marie Duranteau write?
- Marie Duranteau typically writes checks of $100K – $5M.
- Where did Marie Duranteau go to school?
- Marie Duranteau studied at HEC Paris (Master of Science (MSc) - Entrepreneurship, Biotechnology); Université Paris Cité (Doctor of Philosophy (PhD), Cellular Biology); Université Paris Cité (Master's degree, Cellular and Developmental Biology).
Same school
Also attended HEC Paris419
Mathilde CollinCo-founder & Executive Chair of FrontAlexandre ProtCo-founder & CEO of QontoLaura BuhlerPartner, Head of Community at Felicis VenturesCyriac ParisotInvestor at Index VenturesIan MarshInvestor at DN CapitalCeline XiaoInvestor at DN Capital
+ 413 more
Also attended Université Paris Cité54
Michèle OllierInvestor at MedicxiMaija MuntilaTalent Lead at Lifeline VenturesZach WhiteInvestment Team at 8VCCyril CollonGeneral Partner at Partech VenturesIsabelle TressonCommunications & Marketing Lead at Partech VenturesElena BattistelloAnalyst at Novartis Venture Fund
+ 48 more
Also attended Pierre and Marie Curie University51
Thomas WolfCo-founder & Chief Science Officer of Hugging FaceJeff ClavierFounding Partner at Uncork CapitalJean SiniGeneral Partner at Partech VenturesDimitri KrempPrincipal at Axeleo CapitalJack GuedjInvestor at Sand Hill AngelsOphélie LaurinInvestment Associate at World Fund
+ 45 more
Shared employers
Also worked at Sofinnova Partners48
Anne HorganPartner at Cambridge Innovation CapitalLaetitia SchwabPrincipal at SR One Capital ManagementAntoine Papiernik PapiernikChairman and Managing Partner at Sofinnova PartnersGraziano SeghezziManaging Partner at Sofinnova PartnersMichael KrelPartner at Sofinnova PartnersHenrijette RichterManaging Partner at Sofinnova Partners
+ 42 more